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Abstract
On June 14, the U.S. Supreme Court issued an important opinion on the extrater-
ritorial reach of U.S. antitrust laws in F. Hoffmann-La Roche Ltd. v. Empagran,
S.A.1 The opinion, written by Justice Breyer, restricts the extraterritorial applica-
tion of the antitrust laws under the Foreign Trade Antitrust Improvements Act of
1982 (FTAIA). The Court unanimously held that purchasers in overseas markets
claiming injury from price ?xing (or other antitrust violations) cannot sue in U.S.
courts by alleging that they were harmed by conduct that also injured consumers
in the United States, at least absent allegations that injury to U.S. consumers fa-
cilitated the harm to them. The decision, however, leaves open some questions
whether such antitrust claims can be redressed in U.S. courts in limited circum-
stances.
1  Wilmer Cutler Pickering Hale and Dorr LLP represented one of the respondents before the Court.
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On June 14, the U.S. Supreme Court is-sued an important opinion on the extra-territorial reach of U.S. antitrust laws 
in F. Hoffmann-La Roche Ltd. v. Empagran, 
S.A.1  The opinion, written by Justice Breyer, 
restricts the extraterritorial application of the 
antitrust laws under the Foreign Trade Antitrust 
Improvements Act of 1982 (FTAIA).  The Court 
unanimously held that purchasers in overseas 
markets claiming injury from price ﬁxing (or 
other antitrust violations) cannot sue in U.S. 
courts by alleging that they were harmed by 
conduct that also injured consumers in the United 
States, at least absent allegations that injury to 
U.S. consumers facilitated the harm to them.  The 
decision, however, leaves open some questions 
whether such antitrust claims can be redressed in 
U.S. courts in limited circumstances.  
Background
Empagran was a class action brought by 
domestic and foreign vitamin purchasers, who 
claimed that U.S. and non-U.S. vitamin manu-
facturers and distributors had engaged in a global 
price-ﬁxing conspiracy.  The manufacturers and 
distributors moved to dismiss from the suit the 
purchasers that had bought vitamins outside the 
United States. 
 
 The core issue was whether the FTAIA 
permitted plaintiffs that purchased overseas to 
bring Sherman Act suits in U.S. courts.  The 
FTAIA prohibits antitrust suits for transactions 
in foreign commerce – that is, commerce taking 
place entirely outside the United States – unless 
the plaintiff can show that:
(1) The alleged harmful conduct had a “di-
rect, substantial, and reasonably foresee-
able effect” on U.S. commerce; and 
(2) The effect on U.S. commerce gave rise to 
“a” claim under the Sherman Act.  
 The circuit courts were badly split on what 
exactly this language means.  The Fifth Circuit 
ruled in Den Norske Stats Oljeselskap As v. 
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HeereMac VOF, 241 F.3d 420 (5th Cir. 2001), 
that a plaintiff could pursue an antitrust claim 
in U.S. courts only if the plaintiff’s own injury 
arose from the alleged wrongdoing’s effect on 
U.S. commerce.  The Second Circuit, by contrast, 
held in Kruman v. Christie’s Int’l PLC, 284 F.3d 
384 (2d Cir. 2002), that a plaintiff could pursue 
a claim in U.S. courts so long as someone (even 
if not the plaintiff) had a claim based on the 
wrongdoing's effect on U.S. commerce.  In Em-
pagran, the D.C. Circuit largely sided with the 
Second Circuit, and ruled that plaintiffs purchas-
ing overseas could bring suit.
The Supreme Court Opinion
 The Supreme Court reversed.  It began its 
analysis by rejecting the purchasers’ argument that 
the FTAIA applies only to export commerce.  Cit-
ing the FTAIA’s legislative history, the Court held 
that the FTAIA applies to all conduct involving 
foreign, non-import commerce – not just export 
commerce.  Thus, all antitrust suits that claim an 
injury based on conduct involving foreign com-
merce must satisfy the FTAIA’s two-part test.
  
 Next, the Court held that the FTAIA does not 
grant U.S. courts jurisdiction to hear claims based 
on injuries in foreign markets, at least if those 
injuries are independent of harm to consumers in 
the United States.  Accordingly, claims based on 
those foreign effects are beyond the scope of the 
U.S. antitrust laws.  The Court based its ruling on 
principles of comity and the FTAIA’s legislative 
history.  
 First, the Court applied a rule of statutory con-
struction that presumes Congress did not intend 
unreasonably to interfere with the sovereignty of 
foreign nations.  This rule “helps the potentially 
conﬂicting laws of different nations work together 
in harmony – a harmony particularly needed in 
today’s highly interdependent commercial world.” 
The Court rejected the D.C. Circuit’s broad inter-
pretation of the FTAIA because permitting antitrust 
suits based on injuries in foreign markets – at least 
if those injuries are not linked to harm to U.S. con-
sumers – would create a “a serious risk of interfer-
ence with a foreign nation’s ability independently 
to regulate its own commercial affairs.”  
 The Court observed that, though Congress 
may have an interest in addressing foreign con-
duct when it harms U.S. commerce, it generally 
has no reasonable basis to supplant foreign law 
for injuries suffered in foreign commerce.  Even 
if the United States and other sovereigns agree 
that price-ﬁxing is illegal, U.S. antitrust remedies 
differ dramatically from those of foreign jurisdic-
tions.  The Court relied in particular on amicus 
curiae briefs ﬁled by the United States and sev-
eral foreign countries arguing that applying U.S. 
remedies to injuries in foreign commerce would 
undermine foreign countries’ enforcement efforts 
against international cartels.  Among other things, 
antitrust wrongdoers would be discouraged from 
cooperating with foreign authorities if they could 
be held liable for treble damages in U.S. courts 
for their admitted wrongdoing.   
 Second, the Court found support for its inter-
pretation in the FTAIA’s language and legislative 
history.  It concluded that the FTAIA was intended 
to clarify or limit the reach of the U.S. antitrust 
laws to foreign commerce, not to expand it (as 
the foreign purchasers had argued).  The Court 
observed that no case before 1982 speciﬁcally 
permitted plaintiffs to sue for injuries based solely 
on injuries in foreign commerce, and that a leading 
pre-1982 case suggested a contrary rule.  
 The Court also rejected the purchasers’ ar-
gument that the language of the FTAIA, which 
permits suits when the conduct’s domestic effect 
gives rise to “a” claim under the Sherman Act, 
compels a different outcome.  Contrary to the 
Second and D.C. Circuits, the Court held that 
it “makes linguistic sense to read the words ‘a 
claim’ as if they refer to the ‘plaintiff’s claim’ 
or ‘the claim at issue,’” not to construe them as 
permitting a purchaser in a foreign market to sue 
because someone  – though not the plaintiff – has 
“a claim” under the Sherman Act based on the 
wrongdoing.  
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premised on allegations that the unlawful conduct 
also affected U.S. commerce.  We are, in particular, 
likely to have fewer cases in U.S. courts brought 
by consumers injured overseas as a result of 
global antitrust conspiracies.  Further, the Court’s 
emphasis on principles of comity and its narrow 
interpretation of the FTAIA suggest that courts will 
be skeptical of any private claim that is premised on 
injuries in foreign commerce (although the Court 
suggested that extraterritoriality limitations may be 
less stringent when the federal government brings 
an action).  
We are, however, likely to see additional litiga-
tion about whether some plaintiffs that purchased 
overseas can sue in the United States if they can 
allege that their injuries were linked to effects on 
U.S. markets; and, if so, under what circumstances, 
the courts might allow such claims. 
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The Court, though, left open questions about 
whether plaintiffs injured in foreign commerce 
would be barred from bringing suit in the United 
States in all circumstances.  The Court made clear 
that its opinion bore directly only on situations 
when the adverse effect on foreign commerce 
is “independent” of any domestic effect.  It re-
manded the case to the D.C. Circuit to (a) deter-
mine whether the purchasers had preserved any 
argument that the domestic effects of the alleged 
conspiracy were linked to the foreign harm; and 
(b) if so, to decide in the ﬁrst instance whether this 
allegation might provide the courts with jurisdic-
tion under the FTAIA.
Implications of Empagran
 Empagran should put an end to most U.S. 
antitrust suits for injuries in foreign commerce 
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